Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
NCT ID: NCT04557631
Last Updated: 2021-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2021-09-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to compare the results of chronic and excessive ethanol patients with the cut-off proposed in the literature.
* Also assess the stability of phosphatidylethanol in total blood collected, and in blotted dried blood stains (DBS), depending on temperature (ambient temperature and +4°C)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
NCT02580318
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
NCT06864819
Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly
NCT02822911
Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease
NCT02873663
Diurnal Triglyceridemia in Relation to Alcohol Intake
NCT01786421
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person hospitalized for a hospital withdrawal in the addiction service of Lille's hospital, without other distinctions.
Exclusion Criteria
* Patient subject to protective measures (guardianship or curatorship)
* Person deprived of liberty
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier COTTENCIN, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02683-54
Identifier Type: OTHER
Identifier Source: secondary_id
2019_02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.